← back to search

Hong Zhang

King University · US
Area of research
Nephrology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Renal Diseases and Glomerulopathies, Diabetes Treatment and Management, Tracheal and airway disorders, and Anesthesia and Pain Management.
h-index
29
citations
4,265
works
264
NIH funding
primary concept
email

Recent publications

The Correlation Between Symptom Clusters and Quality of Life in Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study
Western Journal of Nursing Research 2025cited by 2position: middledoi
The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design
JAMA Network Open 2024cited by 12position: middledoi
Clinical Application of Polygenic Risk Score in IgA Nephropathy
Phenomics 2024cited by 8position: lastdoi
Prognosis of IgA nephropathy patient with proteinuria remission by supportive therapy: cohort from screening failed Chinese patients in TESTING study
Renal Failure 2024cited by 3position: lastdoi
A model based on immunogenic cell death-related genes predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma
Translational Cancer Research 2024cited by 2position: middledoi
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial
American Journal of Kidney Diseases 2023cited by 27position: middledoi
Comparison of three common shoulder injections for rotator cuff tears: a systematic review and network meta-analysis
Journal of Orthopaedic Surgery and Research 2023cited by 18position: middledoi
New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies
Journal of Clinical Medicine 2022cited by 38position: middledoi
Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity
EBioMedicine 2022cited by 30position: middledoi
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial
Diabetes & Metabolism 2022cited by 20position: middledoi
[Efficacy of plasma exchange in severe crescentic IgA nephropathy: A multicentered, cohort study].
PubMed 2022cited by 3position: lastdoi
Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease
International Journal of Epidemiology 2021cited by 118position: middledoi
Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial
American Journal of Kidney Diseases 2021cited by 52position: middledoi
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of Telitacicept in Patients with IgA Nephropathy and Persistent Proteinuria
Journal of the American Society of Nephrology 2021cited by 4position: lastdoi
Acupuncture of the Beishu acupoint participates in regulatory effects of ginsenoside Rg1 on T cell subsets of rats with chronic fatigue syndrome
Annals of Palliative Medicine 2020cited by 19position: lastdoi
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups
Circulation 2019cited by 286position: middledoi
[Trans-ethnic analysis of susceptibility variants in IgA nephropathy].
PubMed 2019cited by 2position: lastdoi
An autoimmune disease variant of IgG1 modulates B cell activation and differentiation
Science 2018cited by 62position: middledoi
Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis
American Journal of Kidney Diseases 2016cited by 162position: lastdoi
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials
American Journal of Kidney Diseases 2015cited by 479position: middledoi
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis
Canadian Medical Association Journal 2013cited by 306position: middledoi

Grants

STTR Phase I: BedDot: A Contactless Sensor Device for Sleep Activity Monitoring
NSF1940864$225,0002020–2021PIRePORTER
Conference on Statistical Properties of Nonequilibrium Dynamical Systems
NSF1600808$45,0002016–2017PIRePORTER
CAREER: The Nature of SRB Measures for Nonequilibrium Hyperbolic Systems
NSF1151762$400,0012012–2018PIRePORTER
Collaborative Research: Understanding and Optimizing A Supercritical Fluid Process for Recycling of Printed Circuit Boards
NSF1133984$99,7312011–2015PIRePORTER
Statistical Properties of Hyperbolic Systems with Singularities
NSF0901448$118,6862009–2013PIRePORTER
GOALI: Modeling and Optimization of a Responsive Reverse Logistics Channel for Electronic Products
NSF0423465$100,0002004–2007PIRePORTER
PREMISE: Exploratory Research: An Alternative Process Model for Printed Circuit Board Recycling
NSF0225927$113,7822002–2005PIRePORTER
Tolerance Graph for Tolerance Control in Process Planning
NSF9714029$217,6381997–2001PIRePORTER
Research Initiation: A Test Bed of Integrated Process Planning Systems
NSF9211657$89,7321992–1996PIRePORTER
A Continuation Approach to Eigenvalue Problems
NSF9103296$46,8441991–1994PIRePORTER

Frequent collaborators

Jicheng Lv · Clinical Research Institute8 papers (2013–2024)Vlado Perkovic · UNSW Sydney5 papers (2013–2022)Sufang Shi · University of Leicester4 papers (2019–2024)Meg Jardine · Smart Material (Germany)3 papers (2019–2022)Shu‐Feng Zhou · King University3 papers (2019–2024)Hiddo J.L. Heerspink · Kidney Associates3 papers (2019–2022)Dick de Zeeuw · University Medical Center Groningen3 papers (2019–2022)Adeera Levin · Providence Health Care3 papers (2019–2022)David C. Wheeler · University College London3 papers (2019–2022)Bruce Neal · ProCure (United States)3 papers (2019–2022)David M. Charytan · NYU Langone Health3 papers (2019–2022)Xinfang Xie · King University2 papers (2015–2016)George L. Bakris · University of Mississippi2 papers (2019–2022)Carol A. Pollock · Macquarie University2 papers (2019–2022)Guisen Li · University of Electronic Science and Technology of China2 papers (2021–2024)Wanyin Hou · King University2 papers (2015–2016)Kenneth W. Mahaffey · Stanford University2 papers (2019–2022) · 2 papers (2019–2021)Rajiv Agarwal · Brigham and Women's Hospital2 papers (2021–2022) · 2 papers (2019–2022)